19 results
8-K
EX-99.1
BHVN
Biohaven Ltd.
27 Sep 23
Regulation FD Disclosure
6:58am
models Selective and Potent Selective and potent inhibition of TRPM3 provides a novel, non- opioid approach to neuropathic pain treatment Selectivity
10-Q
38iq zxr8t0plft
9 Nov 22
Quarterly report
4:19pm
8-K
EX-99.1
92fbfshe9jfmvxzp57
9 Nov 22
Biohaven LTD. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments
4:05pm
424B4
5g2 w0vxoq4nw8sm9ao
24 Oct 22
Prospectus supplement with pricing info
9:38am
S-1/A
7j0crb0e0dxx6a7
20 Oct 22
IPO registration (amended)
10:00am
S-1
glr 2vpw8v
18 Oct 22
IPO registration
4:03pm
DRS
48v t0tpo
11 Oct 22
Draft registration statement
12:00am
10-12B/A
EX-99.1
eujdr
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
02dw9py
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
hype980mvbkr4q0
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
j4q56dsg 3h8iip0v04f
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-99.1
ii3tj4z voonz6xxpz
10 Aug 22
Registration of securities
5:07pm
DRS
EX-99.1
mroue
1 Jul 22
Draft registration statement
12:00am
- Prev
- 1
- Next